Funding Received
$6 Million in 2 Rounds from 1 Investor
Most Recent Funding
$3.8 Million Series A on June 2, 2014
Headquarters:
Cambridge
Description:
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
Categories:
Biotechnology
Website:
http://definigen.com

Company Details

Update
Founded:
Unknown
Contact:
Employees:
3 in CrunchBase

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programmes. The Company’s proprietary production platform OptiDIFF robustly generates human cell types including liver hepatocytes using hIPSC human Induced Pluripotent Stem Cell technology.

Funding Rounds (2) - $3.8M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    Babraham Research Campus

    Babraham

    Cambridge, CB22 3AT

    GBR

Images (1)

Update
  • 34af3db8775a987af1b74b3d64ae0b31